Introduction Executive Summary Gastroesophageal Reflux disease: Overview ● Causes ● Mechanism of Action ● Signs and Symptoms ● Diagnosis ● Disease Management Pipeline Therapeutics ● Comparative Analysis Therapeutic Assessment ● Assessment by Product Type ● Assessment by Stage and Product Type ● Assessment by Route of Administration ● Assessment by Stage and Route of Administration ● Assessment by Molecule Type ● Assessment by Stage and Molecule Type Gastroesophageal Reflux disease – DelveInsight’s Analytical Perspective In-depth Commercial Assessment ● Gastroesophageal Reflux disease companies’ collaborations, Licensing, Acquisition -Deal Value Trends Gastroesophageal Reflux disease Collaboration Deals ● Company-Company Collaborations (Licensing / Partnering) Analysis ● Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) ● Comparative Analysis Fexuprazan : Daewoong Pharmaceutical ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) ● Comparative Analysis JP 1366: Jeil Pharmaceutical ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) ● Comparative Analysis AD 214: Addpharma ● Product Description ● Research and Development ● Product Development Activities Drug profiles in the detailed report….. Inactive Products ● Comparative Analysis Gastroesophageal Reflux disease Key Companies Gastroesophageal Reflux disease Key Products Gastroesophageal Reflux disease- Unmet Needs Gastroesophageal Reflux disease- Market Drivers and Barriers Gastroesophageal Reflux disease- Future Perspectives and Conclusion Gastroesophageal Reflux disease Analyst Views Gastroesophageal Reflux disease Key Companies Appendix

Table 1 Total Products for Gastroesophageal Reflux disease Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Daewoong Pharmaceutical • Jeil Pharmaceutical • Effexus Pharmaceutical • Addpharma